"In a traditional corneal transplant, the central part of the cornea is removed and a donor cornea is sutured in its place. Image courtesy of Dr. Edward Holland, University of Cincinnati.
Ten years after a transplant, a cornea fro"...
Visudyne Patient Information including How Should I Take
In this Article
- What is verteporfin (Visudyne)?
- What are the possible side effects of verteporfin (Visudyne)?
- What is the most important information I should know about verteporfin (Visudyne)?
- What should I discuss with my health care provider before I receive verteporfin (Visudyne)?
- How is verteporfin given (Visudyne)?
- What happens if I miss a dose (Visudyne)?
- What happens if I overdose (Visudyne)?
- What should I avoid after I receive verteporfin (Visudyne)?
- What other drugs will affect verteporfin (Visudyne)?
- Where can I get more information?
What should I discuss with my health care provider before I receive verteporfin (Visudyne)?
You should not receive this medication if you are allergic to verteporfin, or if you have porphyria (a genetic enzyme disorder that causes symptoms affecting the skin or nervous system).
To make sure you can safely receive verteporfin, tell your doctor if you have other medical conditions, especially:
- liver disease;
- gallbladder disease; or
- if you are receiving radiation treatment.
FDA pregnancy category C. It is not known whether verteporfin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
Verteporfin can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using verteporfin.
How is verteporfin given (Visudyne)?
Verteporfin is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Verteporfin must be given slowly, and the IV infusion can take at least 10 minutes to complete.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
You will receive laser light treatment to your eye(s) within 15 minutes after the start of your verteporfin infusion.
After receiving verteporfin, you must protect your eyes from natural sunlight and bright indoor light for at least 5 days.. For best protection, wear dark sunglasses whenever you are outdoors or while indoors under bright lighting.
You should not stay in the dark while you are indoors, as this can actually cause the drug to stay active in your body longer. It is best to spend your time in ambient indoor light such as indirect sunlight through a window, or low-wattage incandescent lighting. Avoid areas where you will be exposed to halogen or fluorescent light.
Your doctor will need to check your progress on a regular basis. Do not miss any scheduled appointments.
Additional Visudyne Information
- Visudyne Drug Interactions Center: verteporfin iv
- Visudyne Side Effects Center
- Visudyne Overview including Precautions
- Visudyne FDA Approved Prescribing Information including Dosage
Visudyne - User Reviews
Visudyne User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.